⌘K
Loading ticker…
As of 2026-08-24, Amgen Inc (AMGN) has a 3-month relative strength percentile of 88 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 59. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 2.9%, relative volume 0.89×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
AMGN is in a stage 2 uptrend, week 5. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: 16.6% / 25.5%.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Daily range, ATR, beta, and the math for a 1-ADR stop.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
AMGN appears in 1 ETF as of Jun 2026: WBIL at 0.68% weight, $206K notional.
Held by 368 ETFs · $39.6B across latest filings · largest weight 14.54% (BBH).
Top 1 by value, from SEC N-PORT-P filings dated Jun 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| WBIL | 0.68% | $206K | new |
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Strong relative strength with attention running hot versus its own recent norm. The trend is intact but well-noticed; elevated retail attention has historically been associated with softer forward returns. Context, not a call.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
News
Related searches
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | AMGN Jan avg: 4.79% median: 6.78% win: 75% σ: 6.23% n: 4 2022-04-12 → 2026-07-31 | AMGN Feb avg: 0.10% median: -0.14% win: 50% σ: 12.64% n: 4 2022-04-12 → 2026-07-31 | AMGN Mar avg: -0.01% median: 2.48% win: 75% σ: 6.39% n: 4 2022-04-12 → 2026-07-31 | AMGN Apr avg: -3.95% median: -3.65% win: 0% σ: 2.83% n: 5 2022-04-12 → 2026-07-31 | AMGN May avg: 2.02% median: -0.94% win: 40% σ: 8.50% n: 5 2022-04-12 → 2026-07-31 | AMGN Jun avg: 0.39% median: 0.62% win: 60% σ: 4.95% n: 5 2022-04-12 → 2026-07-31 | AMGN Jul avg: 5.13% median: 5.69% win: 100% σ: 1.95% n: 5 2022-04-12 → 2026-07-31 | AMGN Aug avg: 1.12% median: -1.05% win: 50% σ: 5.76% n: 4 2022-04-12 → 2026-07-31 (current) | AMGN Sep avg: -1.69% median: -2.70% win: 25% σ: 4.70% n: 4 2022-04-12 → 2026-07-31 | AMGN Oct avg: 5.05% median: 2.56% win: 50% σ: 10.84% n: 4 2022-04-12 → 2026-07-31 | AMGN Nov avg: 3.88% median: 5.69% win: 75% σ: 11.39% n: 4 2022-04-12 → 2026-07-31 | AMGN Dec avg: -3.65% median: -6.56% win: 25% σ: 7.10% n: 4 2022-04-12 → 2026-07-31 |